We are conducting early safety and efficacy trials for vaccines, as well as treatment options and observational studies in the field of infectiology.

Ongoing Trials

MVA-MERS-S Phase 1b Vaccine Trial (NCT04119440)

TherVacB Phase 1a Trial (NCT05727267)

mEX-TB study – Cohort study

COVID-19 Studies at the UKE

Nationales Pandemie Kohorten Netz des Netzwerk Universitätsmedizin

We further conduct clinical trials in cooperation with the Bernhardt Nocht Center for Clinical Trails ( BNCCT )

CMVictory Phase 3 Trial (NCT05085366)

Completed Trials

MVA-SARS-CoV-2-ST Phase 1b Trial (NCT04895449)

rVSV-ZEBOV (NCT02283099)

MVA-SARS-2-S (NCT04569383)

MVA-MERS-S (NCT04119440)

INFLIXCOVID UK Jena (NCT04922827)

Crit-Cov Study

RECOVER study

COMIHY Study

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment (NCT04292730)

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) (NCT04292899)